Author Question: What should a phlebotomist do to avoid the risk of backflow of an anticoagulant from a blood vacuum ... (Read 175 times)

Melani1276

  • Hero Member
  • *****
  • Posts: 516
What should a phlebotomist do to avoid the risk of backflow of an anticoagulant from a blood vacuum tube into the patient's circulation during blood collection by venipuncture?
 
  What will be an ideal response?

Question 2

Explain how the coagulation of blood can be prevented by the addition of oxalates, citrates, EDTA, or heparin.
 
  What will be an ideal response?



sylvia

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

Answer: The phlebotomist needs to place the patient's arm in a downward position and the tube stopper (top) in the uppermost position to avoid the risk of backflow of an anticoagulant from a blood vacuum tube into the patient's circulation during venipuncture.

Answer to Question 2

Answer: Oxalates, citrates, and EDTA prevent the coagulation of blood by removing calcium and forming insoluble calcium salts. These three anticoagulants cannot be used in calcium determinations; however, citrates are frequently used in coagulation blood studies. EDTA prevents platelet aggregation and is therefore used for platelet counts and platelet function tests. Fresh EDTA-anticoagulated blood allows preparation of blood films with minimal distortion of white blood cells (WBCs). Heparin, a mucopolysaccharide used in assays, such as ammonia and plasma hemoglobin, prevents blood clotting by inactivating the blood-clotting chemicals thrombin and Factor X.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

Alzheimer's disease affects only about 10% of people older than 65 years of age. Most forms of decreased mental function and dementia are caused by disuse (letting the mind get lazy).

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

For a complete list of videos, visit our video library